MANAGEMENT OF THYROTOXICOSIS IN PATIENTS WITH OPHTHALMOPATHY: ANTITHYROID REGIMEN DETERMINED PRIMARILY BY OCULAR MANIFESTATIONS.
Explore the source record for details and available documents.
Antithyroid Agents↗
Biomedical subjects
R M DAY
Publications and source records attributed to R M DAY.
FURTHER STUDIES ON BINDING OF EXOPHTHALMOS-PRODUCING SUBSTANCE BY NORMAL HUMAN SERUM.
Explore the source record for details and available documents.
Animals↗
Optic nerve involvement associated with thyroid dysfunction.
Explore the source record for details and available documents.
Humans↗
Ocular manifestations of thyroid disease. Current concepts.
Explore the source record for details and available documents.
Disease↗
Exophthalmos-inhibiting factor in normal human serum.
Explore the source record for details and available documents.
Blood↗
Removal rate of radiosodium (Na24) from human orbit in Graves's disease and in health.
Explore the source record for details and available documents.
Disease↗
Simulated progression of visual field defects of glaucoma.
Explore the source record for details and available documents.
Glaucoma↗
Simulated progression of visual field defects in glaucoma.
Explore the source record for details and available documents.
Glaucoma↗
Treatment of exophthalmos associated with thyroid dysfunction.
Explore the source record for details and available documents.
Exophthalmos↗